Trial Profile
Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 30 Jun 2016 Status changed from recruiting to completed.
- 30 Jun 2014 New trial record